Glucose variability: An emerging target for the treatment of diabetes mellitus.
about
Glycemic Variability: How Do We Measure It and Why Is It Important?Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus.Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.Is type 2 diabetes really resolved after laparoscopic sleeve gastrectomy? Glucose variability studied by continuous glucose monitoringOscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells.Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.The efficacy and safety of teneligliptin added to ongoing metformin monotherapy in patients with type 2 diabetes: a randomized study with open label extension.Chaotic time series prediction for glucose dynamics in type 1 diabetes mellitus using regime-switching models.Updates on cardiovascular outcome trials in diabetes.Minimizing Glycemic Fluctuations in Patients with Type 2 Diabetes: Approaches and Importance.A strong correlation of glucose variability in non-insulin-treated patients with type 2 diabetes evaluated between continuous glucose monitoring and seven-point testing.Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data.Uncoupling Protein 2 Inhibition Exacerbates Glucose Fluctuation-Mediated Neuronal Effects.Relationship of Glucose Variability With Glycated Hemoglobin and Daily Mean Glucose: A Post Hoc Analysis of Data From 5 Phase 3 Studies.Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).A New Optimized Percutaneous Access System for CIPII.Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes.Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats.Timing of Exercise Affects Glycemic Control in Type 2 Diabetes Patients Treated with Metformin.Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association?
P2860
Q26795377-DEE6D16C-8837-4ABC-95CA-C9C4C48A4440Q31001326-A43DC8E7-C3EF-4B37-9BA9-1B441EEBACB1Q31013668-8181B2CF-5AE5-4A76-ADE4-667E31790B7DQ33928042-BBB07822-B6EA-4B2E-A641-E5FD415F6FDEQ34023548-B2DFBB9F-8327-4891-A196-2471C0DD506FQ34099937-7661FC07-E0D2-4564-8DF9-BF26D78DE8D9Q35543676-C91E4A02-AA50-4545-BE97-1F8A2209561FQ36855706-C949E98E-C247-4B14-B7EA-5FA4A274E795Q38727756-3F508B0A-9D4F-410B-BFAE-1D83BA38A0CAQ40232094-0D740C69-8026-43DF-B186-7DFBED5AE3E2Q40753056-D6D7D25F-0659-4C96-8B28-54EAFE43D1CAQ41109615-04102545-F5B0-476F-857D-DAEC865423FDQ42375211-669616EC-02EE-4F7A-990F-EB16B41973B9Q42380223-3FC71B48-B2A1-4D71-8A2C-D1E3ED692F2FQ43223283-8AC7D77D-F8CC-4A78-917D-2DEC247C690BQ46185031-53F1B24E-3671-4EE9-9A2A-6ECFEA363E69Q46311578-51F0CACD-DABA-4887-AB69-2F0D7AFE12CAQ47748386-EFEF74BA-BEE3-40BA-A9DF-54572DB538F2Q50075924-AFF95EAF-51BA-4CE4-A0F5-9821EDC069B6Q53193621-287DCB6C-3D2F-4C41-9A24-F24993E01CFEQ54961900-16526863-CDAC-4825-AEE6-D4832EDAD65BQ54982674-877B3D63-0D8C-4686-8B1D-ABDBB7198436Q55194697-E666E95F-6183-4186-AB7A-370983B4D328Q55232113-05A0DA6C-1262-46F9-AA22-C9E05ADEE054
P2860
Glucose variability: An emerging target for the treatment of diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Glucose variability: An emerging target for the treatment of diabetes mellitus.
@en
type
label
Glucose variability: An emerging target for the treatment of diabetes mellitus.
@en
prefLabel
Glucose variability: An emerging target for the treatment of diabetes mellitus.
@en
P2093
P50
P1476
Glucose variability: An emerging target for the treatment of diabetes mellitus
@en
P2093
Angelo Avogaro
Emanuele Bosi
Paolo Di Bartolo
P356
10.1016/J.DIABRES.2013.09.007
P577
2013-09-25T00:00:00Z